Caplin Point Laboratories Limited (CAPLIPOINT.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 114.38B |
| Enterprise Value | 108.22B |
| P/E Ratio | 29.26 |
| PEG Ratio | 1.65 |
| Price/Sales Ratio | 8.51 |
| Price/Book Ratio | 5.43 |
| Enterprise/Revenue | 8.24 |
| Enterprise/EBITDA | 21.2 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.29 |
| Operating Margin | 0.31 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 21.87B |
| Revenue/Share | 300.92 |
| Gross Profit | 10.5B |
| EBITDA | 8.76B |
| Net Income | 6.41B |
| Diluted EPS | 84.11 |
Balance Sheet
| Total Cash | 10.07B |
| Total Cash/Share | 132.45 |
| Total Debt | 46.1M |
| Total Debt/Equity | 0 |
| Current Ratio | 6.7 |
| Book Value Per Share | 477.66 |
Price History
| 52-Week Change | 15.82 |
| 52-Week High | 2,699 |
| 52-Week Low | 1,500.3 |
| Moving Average 50 Days | 2,542.61 |
| Moving Average 200 Days | 1,999.17 |
Statistics
| Average Volume | 151,595 |
| Shares Outstanding | 76.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 7 |
| Trailing Annual Dividend Yield | 0.27 |
| Payout Ratio | 0.07 |
| Last Split Factor | 5:1 |
| Last Split Date | October 19, 2016 |
AD
